Go to article: Home | A cure for a costGo to article: In this issueGo to article: SHL Group Company InsightGo to article: Scandinavian HealthGo to article: ContentsGo to article: NewsGo to article: NSFGo to article: VEGA Company Insight Go to article: VEGA AustraliaGo to article: Covid-19 executive briefing by GlobalDataGo to article: The value of real-world evidence during the Covid-19 outbreakGo to article: Covid-19: UK restricts parallel export of nearly 200 drugs, threatening its biopharma industryGo to article: Pharmaceutical professionals say employee safety and supply chain disruption are top Covid-19 concernsGo to article: AbbVie’s, Ascletis’ protease inhibitors spark skeptical outlook for repurposed activity in Covid-19Go to article: PhoenixGo to article: Phoenix Company InsightGo to article: The pharma industry briefingGo to article: No time to waste: repurposing drugs to tackle covid-19Go to article: How safe are simple painkillers?Go to article: Molnar Company Insight Go to article: Molnar-InstituteGo to article: Modelling the human body: a game changer for drug testing?Go to article: Pandemic pricing: existing drugs and price gougingGo to article: Contract Pharmaceuticals Limited CanadaGo to article: Pandemic pricing: novel treatments and vaccinesGo to article: The dark side of anticoagulants: will a new approach shed light?Go to article: Zenatek Go to article: Finding a cure for HIV with ViiV Healthcare and UNC-Chapel HillGo to article: Disputing the facts: is the legal battle between Veeva and IQVIA an antitrust issueGo to article: Nelson LabsGo to article: Could nanoparticles unlock the pharmaceutical benefits of turmeric?Go to article: Why aren’t more companies automating PV data capture?Go to article: Modality SolutionsGo to article: Deals in brief powered by GlobalDataGo to article: The key list powered by GlobalDataGo to article: ButterworthGo to article: Global markets and indices powered by GlobalDataGo to article: Macro-economic indicators (1 of 2) powered by GlobalDataGo to article: Macro-economic indicators (2 of 2) powered by GlobalDataGo to article: MimotopesGo to article: EventsGo to article: Next issue